Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes

126 246

Cited 0 times in

DC Field	Value	Language
dc.contributor.author	이용호	-
dc.date.accessioned	2023-03-03T02:35:08Z	-
dc.date.available	2023-03-03T02:35:08Z	-
dc.date.issued	2022-09	-
dc.identifier.uri	https://ir.ymlib.yonsei.ac.kr/handle/22282913/192856	-
dc.description.statementOfResponsibility	open	-
dc.language	English	-
dc.publisher	Frontiers Research	-
dc.relation.isPartOf	FRONTIERS IN ENDOCRINOLOGY	-
dc.rights	CC BY-NC-ND 2.0 KR	-
dc.subject.MESH	Diabetes Mellitus, Type 2*	-
dc.subject.MESH	Humans	-
dc.subject.MESH	Non-alcoholic Fatty Liver Disease* / drug therapy	-
dc.title	Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes	-
dc.type	Article	-
dc.contributor.college	College of Medicine (의과대학)	-
dc.contributor.department	Dept. of Internal Medicine (내과학교실)	-
dc.contributor.googleauthor	Mohamed Abu-Farha	-
dc.contributor.googleauthor	Yong-Ho Lee	-
dc.contributor.googleauthor	Jehad Abubaker	-
dc.identifier.doi	10.3389/fendo.2022.1010485	-
dc.contributor.localId	A02989	-
dc.relation.journalcode	J03412	-
dc.identifier.eissn	1664-2392	-
dc.identifier.pmid	36120468	-
dc.subject.keyword	GLP1 agonist	-
dc.subject.keyword	NAFLD	-
dc.subject.keyword	SGLT2 (sodium-glucose cotransporter 2) inhibitor	-
dc.subject.keyword	liver fat	-
dc.subject.keyword	thiazolidinediones	-
dc.contributor.alternativeName	Lee, Yong Ho	-
dc.contributor.affiliatedAuthor	이용호	-
dc.citation.volume	13	-
dc.citation.startPage	1010485	-
dc.identifier.bibliographicCitation	FRONTIERS IN ENDOCRINOLOGY, Vol.13 : 1010485, 2022-09	-

Appears in Collections:: 1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

Show simple item record Find it @ YMLIB

YUHSpace: Editorial: Pharmacology and treatment methods for NAFLD in the context of diabetes